Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)
Public ClinicalTrials.gov record NCT00246909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Determination of the Minimal Clinically Important Difference (MCID) of the Patient Orientated Self Assessment Scale ReQuest TradeMark in Patients Suffering From Endoscopically Confirmed Gastroesophageal Reflux Disease (GERD), Grade A-D According to Los Angeles Classification Treated With Pantoprazole 40 mg o.d. or Placebo o.d. Over One Week.
Study identification
- NCT ID
- NCT00246909
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Interventions
- Pantoprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2005
- Primary completion
- Oct 31, 2006
- Completion
- Oct 31, 2006
- Last update posted
- May 6, 2012
2005 – 2006
United States locations
- U.S. sites
- 51
- U.S. states
- 26
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana Pharma/Nycomed | Alabaster | Alabama | 35007 | — |
| Altana Pharma/Nycomed | Huntsville | Alabama | 35801 | — |
| Altana Pharma/Nycomed | Mesa | Arizona | 85213 | — |
| Altana Pharma/Nycomed | Tucson | Arizona | 85723 | — |
| Altana Pharma/Nycomed | Little Rock | Arkansas | 72117 | — |
| Altana Pharma/Nycomed | Anaheim | California | 92801 | — |
| Altana Pharma/Nycomed | Los Angeles | California | 90073 | — |
| Altana Pharma/Nycomed | Orange | California | 92868 | — |
| Altana Pharma/Nycomed | Orange | California | 92869 | — |
| Altana Pharma/Nycomed | Redwood City | California | 94062 | — |
| Altana Pharma/Nycomed | San Diego | California | 92103 | — |
| Altana Pharma/Nycomed | San Diego | California | 92123 | — |
| Altana Pharma/Nycomed | Wheat Ridge | Colorado | 80033 | — |
| Altana Pharma/Nycomed | Torrington | Connecticut | 06790 | — |
| Altana Pharma/Nycomed | Miami | Florida | 33173 | — |
| Altana Pharma/Nycomed | Pembroke Pines | Florida | 33024 | — |
| Altana Pharma/Nycomed | Hines | Illinois | 60141 | — |
| Altana Pharma/Nycomed | Peoria | Illinois | 61602 | — |
| Altana Pharma/Nycomed | Louisville | Kentucky | 40202 | — |
| Altana Pharma/Nycomed | Baton Rouge | Louisiana | 70809 | — |
| Altana Pharma/Nycomed | Shreveport | Louisiana | 71103 | — |
| Altana Pharma/Nycomed | Bethesda | Maryland | 20814 | — |
| Altana Pharma/Nycomed | Hollywood | Maryland | 20636 | — |
| Altana Pharma/Nycomed | Laurel | Maryland | 20707 | — |
| Altana Pharma/Nycomed | Reisterstown | Maryland | 20010 | — |
| Altana Pharma/Nycomed | Towson | Maryland | 21204 | — |
| Altana Pharma/Nycomed | Milford | Massachusetts | 01757 | — |
| Altana Pharma/Nycomed | Jackson | Mississippi | 39202 | — |
| Altana Pharma/Nycomed | Egg Harbor | New Jersey | 08234 | — |
| Altana Pharma/Nycomed | Great Neck | New York | 11021 | — |
| Altana Pharma/Nycomed | Great Neck | New York | 11023 | — |
| Altana Pharma/Nycomed | Johnson City | New York | 13790 | — |
| Altana Pharma/Nycomed | Rochester | New York | 14609 | — |
| Altana Pharma/Nycomed | Raleigh | North Carolina | 27612 | — |
| Altana Pharma/Nycomed | Winston-Salem | North Carolina | 27103 | — |
| Altana Pharma/Nycomed | Cincinnati | Ohio | 45219 | — |
| Altana Pharma/Nycomed | Medford | Oregon | 97504 | — |
| Altana Pharma/Nycomed | Duncansville | Pennsylvania | 16635 | — |
| Altana Pharma/Nycomed | Philadelphia | Pennsylvania | 19147 | — |
| Altana Pharma/Nycomed | Pittsburgh | Pennsylvania | 15218 | — |
| Altana Pharma/Nycomed | Charleston | South Carolina | 29403 | — |
| Altana Pharma/Nycomed | Chattanooga | Tennessee | 37404 | — |
| Altana Pharma/Nycomed | Nashville | Tennessee | 37205 | — |
| Altana Pharma/Nycomed | Houston | Texas | 77024 | — |
| Altana Pharma/Nycomed | Houston | Texas | 77074 | — |
| Altana Pharma/Nycomed | Houston | Texas | 77090 | — |
| Altana Pharma/Nycomed | Salt Lake Citey | Utah | 84107 | — |
| Altana Pharma/Nycomed | South Ogden | Utah | 84405 | — |
| Altana Pharma/Nycomed | Fairfax | Virginia | 22031 | — |
| Altana Pharma/Nycomed | Bellevue | Washington | 98004 | — |
| Altana Pharma/Nycomed | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00246909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2012 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00246909 live on ClinicalTrials.gov.